Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) shot up 2.4% during mid-day trading on Friday . The company traded as high as $1.93 and last traded at $1.92. 4,531,074 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 25,432,521 shares. The stock had previously closed at $1.87.
Tilray Stock Up 3.7 %
The stock has a market cap of $1.50 billion, a P/E ratio of -4.35 and a beta of 2.19. The firm has a 50 day simple moving average of $1.81 and a two-hundred day simple moving average of $1.89. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. During the same period in the previous year, the company earned ($0.15) EPS. The business’s revenue for the quarter was up 24.8% compared to the same quarter last year. Equities research analysts predict that Tilray Inc will post -0.12 earnings per share for the current year.
Institutional Trading of Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
- Five stocks we like better than Tilray
- Breakout Stocks: What They Are and How to Identify Them
- Lumen: Among Top Performers Last Month, Still Has Warning Signs
- How to Use Stock Screeners to Find Stocks
- Baidu’s Strong Quarter Proves a Smart Pick for Michael Burry
- Comparing and Trading High PE Ratio Stocks
- Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.